INVO Bioscience (INVO) Competitors $0.90 +0.09 (+11.11%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INVO vs. SSKN, LYRA, PAVM, PETV, ICU, TTOO, NURO, INBS, PSTV, and STSSShould you be buying INVO Bioscience stock or one of its competitors? The main competitors of INVO Bioscience include STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), PAVmed (PAVM), PetVivo (PETV), SeaStar Medical (ICU), T2 Biosystems (TTOO), NeuroMetrix (NURO), Intelligent Bio Solutions (INBS), Plus Therapeutics (PSTV), and Sharps Technology (STSS). These companies are all part of the "surgical & medical instruments" industry. INVO Bioscience vs. STRATA Skin Sciences Lyra Therapeutics PAVmed PetVivo SeaStar Medical T2 Biosystems NeuroMetrix Intelligent Bio Solutions Plus Therapeutics Sharps Technology INVO Bioscience (NASDAQ:INVO) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, community ranking, dividends, risk, institutional ownership, media sentiment and analyst recommendations. Is INVO or SSKN more profitable? STRATA Skin Sciences has a net margin of -28.72% compared to INVO Bioscience's net margin of -122.79%. INVO Bioscience's return on equity of 0.00% beat STRATA Skin Sciences' return on equity.Company Net Margins Return on Equity Return on Assets INVO Bioscience-122.79% N/A -36.94% STRATA Skin Sciences -28.72%-69.33%-17.55% Which has more risk & volatility, INVO or SSKN? INVO Bioscience has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Which has preferable earnings & valuation, INVO or SSKN? INVO Bioscience has higher earnings, but lower revenue than STRATA Skin Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINVO Bioscience$5.77M0.59-$8.03MN/AN/ASTRATA Skin Sciences$33.36M0.39-$10.83M-$2.66-1.17 Does the MarketBeat Community prefer INVO or SSKN? STRATA Skin Sciences received 216 more outperform votes than INVO Bioscience when rated by MarketBeat users. Likewise, 63.90% of users gave STRATA Skin Sciences an outperform vote while only 46.67% of users gave INVO Bioscience an outperform vote. CompanyUnderperformOutperformINVO BioscienceOutperform Votes746.67% Underperform Votes853.33% STRATA Skin SciencesOutperform Votes22363.90% Underperform Votes12636.10% Does the media prefer INVO or SSKN? In the previous week, STRATA Skin Sciences had 9 more articles in the media than INVO Bioscience. MarketBeat recorded 9 mentions for STRATA Skin Sciences and 0 mentions for INVO Bioscience. INVO Bioscience's average media sentiment score of 0.00 beat STRATA Skin Sciences' score of -0.12 indicating that INVO Bioscience is being referred to more favorably in the media. Company Overall Sentiment INVO Bioscience Neutral STRATA Skin Sciences Neutral Do insiders and institutionals hold more shares of INVO or SSKN? 12.0% of INVO Bioscience shares are held by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are held by institutional investors. 3.5% of INVO Bioscience shares are held by insiders. Comparatively, 39.0% of STRATA Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummarySTRATA Skin Sciences beats INVO Bioscience on 8 of the 13 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INVO vs. The Competition Export to ExcelMetricINVO BioscienceSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.10M$4.47B$5.06B$8.89BDividend YieldN/A36.79%4.97%4.06%P/E RatioN/A12.8689.0213.30Price / Sales0.5445.351,207.2881.01Price / CashN/A52.2339.1736.03Price / Book-0.395.676.085.74Net Income-$8.03M$13.76M$119.07M$225.93M7 Day Performance-3.68%-1.08%-1.84%-1.32%1 Month Performance-2.40%0.58%-3.65%0.60%1 Year Performance-56.29%50.91%31.62%26.23% INVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INVOINVO BioscienceN/A$0.90+11.1%N/A-52.7%$3.43M$5.77M0.0025Gap UpSSKNSTRATA Skin Sciences0.5693 of 5 stars$3.10+0.3%N/A-40.7%$12.93M$33.36M0.00120LYRALyra Therapeutics3.3367 of 5 stars$0.19+4.0%$4.50+2,329.8%-94.1%$12.12M$1.56M0.0050Analyst RevisionNews CoveragePAVMPAVmed3.9986 of 5 stars$1.03flat$21.00+1,938.8%-68.7%$11.40M$2.45M-0.2490PETVPetVivoN/A$0.53+12.5%N/A-33.7%$10.90M$970,000.00-0.9820ICUSeaStar Medical0.2875 of 5 stars$2.20+2.3%N/A-82.8%$9.81MN/A0.002Gap UpTTOOT2 Biosystems2.4558 of 5 stars$0.44-5.8%$5.00+1,049.2%-88.3%$9.16M$7.19M0.00180NURONeuroMetrix0.5217 of 5 stars$4.16-4.1%N/A+11.5%$8.49M$5.90M0.0020Analyst ForecastNews CoverageGap DownINBSIntelligent Bio Solutions0.331 of 5 stars$1.63+16.4%N/A-61.1%$7.16M$3.11M0.0010News CoverageGap UpPSTVPlus Therapeutics3.2264 of 5 stars$1.20+0.8%$14.00+1,066.7%-37.4%$7.08M$4.91M0.0020Analyst RevisionGap UpSTSSSharps Technology0.7782 of 5 stars$3.52+9.0%N/AN/A$6.34MN/A-0.383Gap Down Related Companies and Tools Related Companies STRATA Skin Sciences Competitors Lyra Therapeutics Competitors PAVmed Competitors PetVivo Competitors SeaStar Medical Competitors T2 Biosystems Competitors NeuroMetrix Competitors Intelligent Bio Solutions Competitors Plus Therapeutics Competitors Sharps Technology Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INVO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
